Fluoxetine vs control at end of treatment,: Death
Fluoxetine showed no clear difference in death compared with control at end of treatment, (moderate certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Fluoxetine vs control at end of treatment, Death · people with stroke recovery Fluoxetine showed no clear difference in death compared with control at end of treatment, (moderate certainty). Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery (2021) · Cochrane Headline outcomes only | RR 1.01 [0.82, 1.24] | 6 studies · 6090 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery 2021 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.